100 related articles for article (PubMed ID: 12013785)
1. Mass spectrometric quantification of F2-isoprostanes as indicators of oxidant stress.
Morrow JD; Roberts LJ
Methods Mol Biol; 2002; 186():57-66. PubMed ID: 12013785
[No Abstract] [Full Text] [Related]
2. Ion trap tandem mass spectrometric determination of F2-isoprostanes.
Signorini C; Comporti M; Giorgi G
J Mass Spectrom; 2003 Oct; 38(10):1067-74. PubMed ID: 14595856
[TBL] [Abstract][Full Text] [Related]
3. Separation and identification of F2-isoprostane regioisomers and diastereomers by novel liquid chromatographic/mass spectrometric methods.
Yin H; Porter NA; Morrow JD
J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Nov; 827(1):157-64. PubMed ID: 15890564
[TBL] [Abstract][Full Text] [Related]
4. Key issues in F2-isoprostane analysis.
Nourooz-Zadeh J
Biochem Soc Trans; 2008 Oct; 36(Pt 5):1060-5. PubMed ID: 18793189
[TBL] [Abstract][Full Text] [Related]
5. Quantification of F2-isoprostanes by gas chromatography/mass spectrometry as a measure of oxidant stress.
Musiek ES; Morrow JD
Curr Protoc Toxicol; 2005 Jun; Chapter 17():Unit 17.6. PubMed ID: 23045115
[TBL] [Abstract][Full Text] [Related]
6. F(2)-isoprostanes: sensitive biomarkers of oxidative stress in vitro and in vivo: a gas chromatography-mass spectrometric approach.
Wiswedel I
Methods Mol Biol; 2009; 580():3-16. PubMed ID: 19784591
[TBL] [Abstract][Full Text] [Related]
7. Quantification of F2-isoprostanes in biological fluids and tissues as a measure of oxidant stress.
Milne GL; Yin H; Brooks JD; Sanchez S; Jackson Roberts L; Morrow JD
Methods Enzymol; 2007; 433():113-26. PubMed ID: 17954231
[TBL] [Abstract][Full Text] [Related]
8. Quantification of F2-isoprostanes as a biomarker of oxidative stress.
Milne GL; Sanchez SC; Musiek ES; Morrow JD
Nat Protoc; 2007; 2(1):221-6. PubMed ID: 17401357
[TBL] [Abstract][Full Text] [Related]
9. Urinary 8-epi-PGF2alpha and its endogenous beta-oxidation products (2,3-dinor and 2,3-dinor-5,6-dihydro) as biomarkers of total body oxidative stress.
Nourooz-Zadeh J; Cooper MB; Ziegler D; Betteridge DJ
Biochem Biophys Res Commun; 2005 May; 330(3):731-6. PubMed ID: 15809058
[TBL] [Abstract][Full Text] [Related]
10. Effect of resistance exercise and carbohydrate ingestion on oxidative stress.
McAnulty SR; McAnulty LS; Nieman DC; Morrow JD; Utter AC; Dumke CL
Free Radic Res; 2005 Nov; 39(11):1219-24. PubMed ID: 16298748
[TBL] [Abstract][Full Text] [Related]
11. Using isoprostanes as biomarkers of oxidative stress: some rarely considered issues.
Halliwell B; Lee CY
Antioxid Redox Signal; 2010 Jul; 13(2):145-56. PubMed ID: 20001743
[TBL] [Abstract][Full Text] [Related]
12. Polyunsaturated fatty acid pattern in liver and erythrocyte phospholipids from obese patients.
Elizondo A; Araya J; Rodrigo R; Poniachik J; Csendes A; Maluenda F; Díaz JC; Signorini C; Sgherri C; Comporti M; Videla LA
Obesity (Silver Spring); 2007 Jan; 15(1):24-31. PubMed ID: 17228028
[TBL] [Abstract][Full Text] [Related]
13. Oxidant stress is increased during treatment of human immunodeficiency virus infection.
Hulgan T; Morrow J; D'Aquila RT; Raffanti S; Morgan M; Rebeiro P; Haas DW
Clin Infect Dis; 2003 Dec; 37(12):1711-7. PubMed ID: 14689356
[TBL] [Abstract][Full Text] [Related]
14. Oxidant stress modulates murine allergic airway responses.
Talati M; Meyrick B; Peebles RS; Davies SS; Dworski R; Mernaugh R; Mitchell D; Boothby M; Roberts LJ; Sheller JR
Free Radic Biol Med; 2006 Apr; 40(7):1210-9. PubMed ID: 16545689
[TBL] [Abstract][Full Text] [Related]
15. Quantification of urinary F2-isoprostanes with 4(RS)-F4t-neuroprostane as an internal standard using gas chromatography-mass spectrometry Application to polytraumatized patients.
Mas E; Michel F; Guy A; Bultel V; Falquet Y; Chardon P; Rossi JC; Cristol JP; Durand T
J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Sep; 872(1-2):133-40. PubMed ID: 18706873
[TBL] [Abstract][Full Text] [Related]
16. Is oxidant stress a connection between obesity and atherosclerosis?
Morrow JD
Arterioscler Thromb Vasc Biol; 2003 Mar; 23(3):368-70. PubMed ID: 12639824
[No Abstract] [Full Text] [Related]
17. [Bioactive isoprostanes. New markers of oxidative stress and inflammation-related diseases].
Basu S; Helmersson J
Lakartidningen; 2009 Jan 28-Feb 3; 106(5):274-8. PubMed ID: 19271455
[No Abstract] [Full Text] [Related]
18. Quantification of dinor, dihydro metabolites of F2-isoprostanes in urine by liquid chromatography/tandem mass spectrometry.
Davies SS; Zackert W; Luo Y; Cunningham CC; Frisard M; Roberts LJ
Anal Biochem; 2006 Jan; 348(2):185-91. PubMed ID: 16309621
[TBL] [Abstract][Full Text] [Related]
19. F2-isoprostanes as markers of oxidative stress in vivo: an overview.
Milne GL; Musiek ES; Morrow JD
Biomarkers; 2005 Nov; 10 Suppl 1():S10-23. PubMed ID: 16298907
[TBL] [Abstract][Full Text] [Related]
20. Alteration of plasma total F2-isoprostanes before and after hemodialysis in end-stage renal disease patients.
Kim KM; Jung BH; Paeng KJ; Kim SW; Chung BC
Prostaglandins Leukot Essent Fatty Acids; 2004 May; 70(5):475-8. PubMed ID: 15062851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
